) levels in the patient group.
Introduction
Stroke is the third cause of mortality in the world. According to the World Health Organization (WHO), about 5.71 million people suffered from stroke in 2004, and it is estimated that this number will increase to 6.3 and 7.8 million in 2015 and 2030, respectively [1] .
Statins are recommended as a cholesterol-lowering agent in developing countries. Plant sterols are used as alternative treatment protocol. Firstly, sterols were inserted in margarine and used in Europe in 1997. The most frequent phytosterols in the human diet are β-sitosterol, campesterol and stigmasterol, (almost 65%, 30% and 3% of diet ingredients, respectively). The phytosterols to limit the absorption of cholesterol were first recognized in 1953 [2] .
Although the chemical structure of phytosterols are very similar to cholesterol, they are differentiated according to differences in the cholesterol side-chain group [3] [4] [5] [6] . Their cholesterol-lowering properties are not well-known. They compete with cholesterol for dissolution in the micelles and therefore inhibit intestinal absorption of both dietary and endogenous cholesterol [6] .
Phytosterols cannot be synthesized by humans and, therefore, should be avoided from the diet. Over 40 phytosterols have been defined; of these, stigmasterol, campesterol, and β-sitosterol constitute more than 95% of total dietary intake [7] .
Sitosterolemia, defined as phytosterolemia, is a rare autosomal recessive disease characterized by elevated blood sterol levels, induced by raised intestinal absorption and reduced biliary drain of plant sterols. Sitosterolemia is due to mutations of some ATP-binding cassette (ABC), ABCG5 and ABCG8 protein genes. ABC transport proteins reduce the sterol absorption in intestinal cells by pumping back the plant sterols into the intestinal lumen [8] .
Vitamin B12 and folate deficiency, especially in population over the age of 55, leads to increased levels of serum methylmalonic acid and homocysteine concentrations. Increased methylmalonic acid levels in the urine were found to be associated with ischemic stroke [9] . Homocysteine is considered to play a role in the pathogenesis of ischemic stroke. Homocysteine (Hcy) is a cause of atherogenesis and thrombogenesis due to endothelial damage, coagulation disorders and vascular smooth muscle proliferation [10] .
Low-density lipoprotein cholesterol (LDL-cholesterol) contains not only cholesterol, but also plant sterols (i.e., campesterol, sitosterol, and avenasterol) [11] . The former stages of oxidized LDL (Ox-LDL) formation is the peroxidation of polyunsaturated fatty acids in its structure [12] .
Plasma stanol levels were found to decrease sterol levels but increase the hemorragic stroke risk compared to sterols in hypertensive rats vulnerable to stroke [13] . Urinary methylmalonic acid levels were found to be associated with ischemic stroke [9] . Low serum High density lipoprotein cholesterol (HDL-cholesterol) and triglyceride levels have been concluded to be related with post-acute ischemic stroke mortality [14] .
The aim of this study was to investigate serum plant sterols, methylmalonic acid, vitamin B12, Ox-LDL and homocysteine levels in ischemic and hemorrhagic stroke patients and healthy subjects. To the best of our knowledge, this study is the first on Turkish population.
Material and Methods

Study Population
This study was performed on 50 healthy subjects (26 male, 24 female) aged between 56-64 years (without a family history of coronary artery disease) and 89 patients (49 male, 40 female) aged between 54-69 years hospitalized in the Selcuk University neurology clinic or intensive care unit with a diagnosis of stroke. Patients with steroid therapy for acute stroke, with a medication history of anti-hyperlipidemic drug, alcohol consumption, vegetarian diet, malignancy, infection, end-stage liver and kidney disease, vitamin B12 and folic acid therapy were excluded. We obtained 8-10 ml of whole blood and urine samples from patients after 12-14 hours of fasting on the first day. Serum samples were immediately seperated after coagulation and stored at -85˚C until the day of analysis. Serum total cholesterol, triglycerides, HDL-cholesterol, LDL-cholesterol, vitamin B12, plant sterols (stigmasterol, β-sitosterol), Ox-LDL, serum methylmalonic (SMMA), urinary methylmalonic acid (UMMA) and homocysteine levels were analyzed. The study was approved by Selcuk University non-invasive Clinical Research Ethics Committee (Number of approval: 2013/07)
Laboratory Procedures
Serum Ox-LDL levels were determined by using a commercially available kit (Mercodia Oxidized-LDL ELISA kit, Cat no: 10-1143-01). Serum total-cholesterol, HDL-cholesterol and triglyceride levels were analyzed using a commercially available kit (Abbott cat no:91752UN16, 48507UQ10, 12603UN16, respectively) on Abbott Architect c16000 autoanalyzer. LDL-cholesterol levels were calculated by Friedewald Formula. Serum vitamin B12 levels were measured using a commercially available kit (Roche; cat no:11427004) on Roche Cobas e-170 autoanalyzer with chemiluminescence method. Serum homocysteine levels were determined by LC-MS/MS (Liquid Chromatography Tandem Mass Spectrometry) as previously described by Rafii et al. [16] with minor modifications. Briefly, 50 µL plasma, calibrator and control samples were mixed with 50µL internal standard (10µM d8-homocysteine isotope DLM-3619-1) and 50 µL reducing reagent (300 mmol/L 1,4-Dithiothreitol) and incubated at room temperature for 15 minutes. 300 µL of precipitating reagent (15% trichloroacetic acid Cat No: Merck 100810) was added to precipitate proteins, mixed for 10 seconds and centrifuged at 13.000 rpm for 3 minutes. 10 µL of supernatant was injected into the analytical column for chromatography (Figure 1 ).
Serum and urinary methylmalonic acid levels were determined by LC-MS/MS (Liquid Chromatography Tandem Mass Spectrometry) as previously described by Kushnir et al. [17] with minor modifications. Briefly, 100 µL of internal standard (2µM d3-methylmalonic acid) in water was incorporated in 1000 µL standard, serum and urine (0.1 mL of specimen and 0.9 mL of water) and 3 ml methyl tert butyl ether (MTBE) (containing 30 ml/L of phosphoric acid) and mixed for 5 min and centrifuged at 3000 rpm for 10 minutes to avoid the precipitated proteins. The supernatant was collected and dried under a nitrogen gas flow, and 40 µL of n-butanol including 3 mol/L HCl was added. The mixture was incubated at 60 °C for 35 minutes and dried under a nitrogen gas flow. The samples were diluted with 75 µL of a mixture of methanol-0.005 mol/L ammonium formate (1/1, v/v) and transported to labeled autosampler vials and injected into analytical column for chromatography. Mass spectrometric assay was performed by Shimadzu LC-20-AD (Kyoto, Japan) coupled with a ABSCIEX API 3200 triple quadrupole mass spectrometer (USA) with an electrospray ion source (ESI) operating in positive mode. Results were calculated with Analyst software and processed for calibration and quantification of the analytes with Quantitation Wizard Analyst Software 1.6.1 by ABSCIEX Technical Services (USA) (Figure 2) .
Serum plant sterol levels were determined by GC-MS (gas chromatography-mass spectrometry) as described by Ahmida et al. [15] with minor modifications. Briefly, 20 µL of internal standard 
Statistical Analysis
Statistical analysis was performed with SPSS v16. Student's t-test and Mann-Whitney U-test were used for parametric (Ox-LDL, homocysteine, vitamin B12, triglycerides, methylmalonic acid, stigmasterol, β-sitosterol and β-sitosterol/ cholesterol ratio) and non-parametric variables (cholesterol, HDL-cholesterol, LDL-cholesterol and stigmasterol/cholesterol ratio), respectively. Pearson and Spearman correlation tests were performed for parametric and non-parametric tests. Data were expressed as mean±(standard deviation) ( ±SD). Results were considered statistically significant at P<0.05.
Results
Laboratory results are presented in Table 1 and Table 2 . UMMA levels of the patient group were significantly (P<0.01) lower than in the control group, UMMA/creatinine ratio (P<0.05), β-sitosterol and β-sitosterol/cholesterol ratio levels were significantly higher (P<0.01) in the patient group compared to controls. There was no statistically significant difference for other laboratory parameters.
There were significant positive correlations between the OxLDL-SMMA, homocysteine-MMA/creatinine ratio, SMMA-UM-MA (P<0.05), homocysteine-UMMA, UM-MA-MMA/creatinine ratio, SMMA-MMA/ creatinine ratio, Betasitosterol-Betasitosterol/ cholesterol ratio, cholesterol-HDL, cholesterol-LDL (P<0.01) levels and negative correlations between Vitamin B12-SMMA (P<0.05), cholesterol-stigmasterol/cholesterol ratio, LDL-stigmasterol/cholesterol ratio (P<0.01) levels in the patient group.
Significant positive correlations were also found between SMMA-UMMA (P<0.05), UM-MA-MMA/creatinine ratio, Betasitosterol-Betasitosterol/cholesterol ratio, cholesterol-LDL (P<0.01) levels and negative correlations between the levels of cholesterol-HDL (P<0.05), cholesterol-stigmasterol/cholesterol ratio, HDL-LDL and LDL-stigmasterol/cholesterol ratio (P<0.01) levels in the control group. 
Discussion
To the best of our knowledge, this is the first study investigating serum plant sterols, Ox-LDL, homocysteine, methylmalonic acid, vitamin B12 levels and correlations between these parameters in stroke patients.
Sitosterolemia is a genetic disease. Genetic factors, environmental factors and dietary habits may play an important role in the absorption of plant sterols. Therefore, the measurement of these sterols in our region's population is of great importance. Although there is no clinically important elevation of cholesterol levels, premature coronary heart disease has been reported to develop in patients with sitosterolemia [8] . In our study, β-sitosterol and β-sitosterol/cholesterol ratio levels of the patients were significantly higher compared to the control group. This phenomenon may increase the susceptibility to stroke. In addition, a significant positive correlation was found between betasitosterol-betasitosterol /cholesterol ratio levels in the patient group. This might be due to plant sterols to reduce the absorption of cholesterol at high levels. There is no other study investigating the levels of sitosterol in stroke patients.
Consumption of phytosterols has been reported to protect against heart attack and stroke. Phytosterols have anti-inflammatory, antibacterial, antifungal, antiulcerogenic and anti-tumoral activity [18] . Mammals do not synthesize phytosterols. Plant sterol supplementation disturbs endothelial function, exacerbates ischemic brain injury, effects atherogenesis in mice [19] . Ogawa et al. [20] have reported that the supplementation of phytosterol to soybean oil raised systolic blood pressure and supported the onset of stroke, which may cause reduced survival time in stroke-prone spontaneously hypertensive rats. Significant reduction in the intestinal mRNA expression of ABCG5 and ABCG8 might be responsible in stroke-prone spontaneously hypertensive rats.
Total cholesterol and LDL-cholesterol levels in the hypercholesterolemic patient group with a 6-week phytosterol consumption with lowfat fermented, natural plant sterol esters enriched milk were found to have significant reduction compared to control group [21] . Positive correlation was found between betasitosterol-betasitosterol /cholesterol ratio levels in the patients group. These findings were compatible with the resuts of our study.
It was reported that the homocysteine causes vascular damage [22] and induces procoagulant activity [23] . On the other hand, Kara et al. [9] have found no significant difference in serum vitamin B-12, folate and homocysteine levels between the patients with ischemic stroke and control groups. Urinary MMA concentrations and erythrocyte folate levels were significantly higher in patients compared to controls. In addition, urinary MMA/creatinine ratio was significantly higher in the patient group. These findings are not consistent with our results. In our study, there was no significant difference between patients and control groups for urinary MMA/creatinine ratio. The possible cause for this finding might be due to methlymalonic acid quantitation method. In our study, mass spectrometric detection was performed. Kara et al. [9] analyzed this parameter with flourometric detection. The number of the participants in our study was also higher compared to Kara et al. [9] .
Conclusion
In conclusion, our results presented that serum sitosterol levels are significantly higher in patients with stroke compared to controls. Therefore, routine measurement of serum levels of sitosterol in patients with stroke might be considered to identify patients with possible sitosterolemia and for treatment. There were no significant differences for serum homocysteine, stigmasterol and Ox-LDL levels between the patient and control groups in our study.
